All posts tagged in is examining whether AstraZeneca staff were involved in importing an unapproved liver cancer drug into mainland China. Authorities are also scrutinising the company’s patient data collection practices

In a significant development for the pharmaceutical giant AstraZeneca, Chinese authorities have reportedly detained five current and former employees as part of an investigation into potential breaches of data privacy